Translational Research in Hearing and Balance

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 13 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Translational Research in Hearing and Balance
Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

All individuals had been pre-assigned to one of four discussion groups focusing on differing areas of research pertinent to translational research in hearing and balance (Molecular Diagnostic/Therapeutics, Bridging Basic Science to Clinical Science, Clinical Studies, Introduction and Emergence into Clinical Practice). Pre-meeting discussion among participants...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

All individuals had been pre-assigned to one of four discussion groups focusing on differing areas of research pertinent to translational research in hearing and balance (Molecular Diagnostic/Therapeutics, Bridging Basic Science to Clinical Science, Clinical Studies, Introduction and Emergence into Clinical Practice). Pre-meeting discussion among participants was encouraged. On the first day of the workshop, in conjunction with several invited NIH speakers, each of the 4...

Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

All individuals had been pre-assigned to one of four discussion groups focusing on differing areas of research pertinent to translational research in hearing and balance (Molecular Diagnostic/Therapeutics, Bridging Basic Science to Clinical Science, Clinical Studies, Introduction and Emergence into Clinical Practice). Pre-meeting discussion among participants was encouraged. On the first day of the workshop, in conjunction with several invited NIH speakers, each of the 4 groups presented issues and discussion that had emerged from the pre-meeting teleconferences. On the second day, each group then presented research needs and opportunities for action. The agenda with links to presentations from both the first and second days can be found at the website above.

The workshop began with an introductory presentation by Amy Donahue, Ph.D. The history, organization, definitions and scientific portfolio coding strategy used for the purpose of the workshop was provided. Dr. Donahue also provided some overview information on the NIH Roadmap. Thomas Miller, Ph.D., from the National Institute on Neurological Disease and Stroke (NINDS), and Bruce Cuthbert, Ph.D., National Institute on Mental Health (NIMH), presented translational research programs for which they are responsible within their own NIH Institute. Jochen Schacht, Ph.D. presented a case history of translational research experiences and obstacles as related to aminoglycoside-induced HL and antioxidants.

Following this introductory session, the panel on Molecular Diagnostic/Therapeutics presented their considered issues and ideas, followed by the panel on Bridging Basic Science to Clinical Science. After lunch, Katherine Woodbury Harris, Ph.D., presented information on a NIDCD preliminary clinical studies program. Presentations from the panel on Clinical Studies and the panel on Introduction and Emergence into Clinical Practice ended the first day. Each panel reconvened in the evening for additional discussion and formulation of recommendations.

On the second morning, Katherine Zoon, Ph.D. National Cancer Institute presented on FDA requirements necessary to move from a newly identified molecule to human testing. Each of the four panels then presented their recommendations/suggested actions, during which there was considerable and active group discussion.

Following are the abbreviated recommendations:

Panel 1: Molecular Diagnostic/Therapeutics, Lauren Bakaletz, Ph.D. (Chair)

Overall goal: Capitalize on the uniqueness of NIDCD (i.e. many of our disorders are preventable) to develop a model for the creation of an evidence based medicine rationale for TR. To achieve this goal: Establish stepwise developmental milestones for TR, thus providing both guidelines for, as well as a mechanism to demonstrate, forward progress/success (to be conducted in a sequential or parallel manner depending on relative state of development): epidemiological studies, development of animal models, studies of molecular mechanisms, pharmacokinetics and pathophysiology, and conduct of clinical studies.

  • Support a Framingham-type epidemiological study (or fund add-on outcome measures to an existing/planned study) to specifically address sensory disorders (natural history, prevalence, treatment effectiveness, disease parameters).
  • Support the establishment of an NIH-based Clinical Trials Center (e.g. TR Center) that is open to all institutes to review existing ‘basic’ and pre-clinical data in consultation with PIs, identify missing or gaps in data needed for progression to clinic, develop necessary investigation device documents, provide resources for good manufacturing practices product development, and to provide design for and conduct all needed clinical trials.
  • Support mechanisms to disseminate/communicate positive results of trials conducted by the Clinical Trials Center or any other clinical recommendations.
  • NIDCD should take a leadership position in mobilizing the public community/ developing public awareness of sensory disorders as a public health issue as a mechanism to provide much-needed patient advocacy in support of initial and continuing TR initiatives (toxic noise, presbyacusis, vaccines for otitis media, aminoglycoside-induced ototoxicity).
  • Continue to support goal-oriented ‘basic’ TR initiatives via the issuance of an RFA/PAR with a focus on the following areas of research related to sensory disorders (e.g. systems for delivery of substances to the inner and middle ear, pharmacology (toxicity), pharmacokinetics, pathophysiology). [This recommendation is not intended to exclude/subvert the R01 process but rather serve as an adjunct to this mechanism; goal could perhaps also be achieved via rapidly-reviewed ‘TR supplements” to existing R01s].

Panel 2: Bridging Basic Science to Clinical Science, Joe Miller, Ph.D. (Chair)

  • Define TR: The creation of new technologies (broadly defined) from basic research discoveries to improve health care and quality of life, including clinical and outcome research.
  • Create new and effective funding mechanisms for TR (especially the early phase) with special review committee (e.g., R21, R24, R01 (or P50); R03, R01; SBIR from phase 1 to phase 2).
  • Establish review criteria and mechanism for identifying promising TR with high potential socio-economic and health benefits’.
  • Disseminate information about funding and merits of TR (PAs, RFAs, RFPs, workshops (i.e., ARO)).
  • Based upon the identification of promising basic science, encourage basic research (BR) scientists to engage in TR and interdisciplinary collaborative research (including multi-institutional) activities.
  • Encourage academia-industrial collaboration/partnership (invite industry input into TR mechanism that would encourage participation and cost sharing).
  • Educate Center for Scientific Review (CSR), study section members and academic leaders in the importance of TR.
  • Continue to build regional core facilities (P30).
  • Continue mentoring awards for young faculty (e.g., specific TR training, facilitate transition into TR project).
  • Collaborate with other institutions to develop comprehensive epidemiological data base in hearing/balance disorders.
  • Maintain a healthy level of funding for BR; minimize direct competition between BR and TR (varying opinions on whether there should be a special allocation for TR vs. no special allocation for TR).

Panel 3: Clinical Studies, Bruce Gantz, M.D. (Chair)

  • Invigorate the Clinical Research Initiative.
    Clinical Research Planning Grant Mechanism with NIDCD Review.
    Multi-institutional Clinical Research Infrastructure Grants with NIDCD Review
    Develop Clinical Research Supplement for RO1.
    Foster the development of a Clinical Research Data Base that could be used across institutions.
    Homogenize Regulatory Mechanisms across institutions.
    Develop practice-based research networks.
    Promote translational research using mechanism that rewards clinical research-basic science research collaboration.
  • Increase the number of qualified clinical investigators (MD and PhD Audiologists, PhD’s in other disciplines).
    Make it more attractive for young faculty to enter clinical research (i.e., use training (T) and career development (K) mechanisms to promote Clinical Research Track; provide a transition period of support following completion of K).
    Support Shadow Programs (e.g., basic scientist would spend a short period of time in a clinical setting and a clinician scientist would spend a short period of time in a basic science setting).
    Identify successful clinical clinician/scientist and develop programs to teach mentoring.
  • Create an Advisory Committee of experienced clinicians to advise NIDCD on clinical studies/trial development (could formulate relevant clinical questions, suggest RFA’s for new clinical trials, and study and make recommendations for expanded NIDCD clinical research focus- Develop Strategic Plan).
  • Encourage the NIDCD to have an expanded workshop devoted to clinical research and clinical trials.

Panel 4: Emergence into Clinical Practice, Mary Pat Moeller, Ph.D. (Chair)

  • Increase NIDCD’s role in the dissemination of research evidence (i.e., promote systematic reviews of evidence, and identify evidence needs in priority areas).
  • Foster collaborations with related agencies focused on outcomes/dissemination.
  • Increase evidence-based training opportunities (mentorship, cross-disciplinary study, promoting the use of evidence-based medicine tools).
  • Develop reporting standards (MOOSE, CONSORT) to improve the usefulness of published data to guide science and policymakers.
  • Promote the use of participatory research methods (i.e., alignments with advocacy groups, and technical support from experienced R25s).
  • Identify and re-evaluate priority areas, selecting outcomes with broad health impact.
  • Sponsor conferences with TR focus (should be cross-disciplinary and include communication research).
  • Define the ideal role/components of TR Centers.
  • Continue to support the NIDCD dissemination function.
  • Continue to support research in health communication.
  • Continue to support efforts in epidemiology.

References

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Translational Research in Hearing and Balance

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Anti-Androgens Therapy

    Anti-androgen therapy refers to medication taken by women to counteract the effect of male sex hormones such as testosterone on the skin. Anti-androgens are not suitable for skin problems in men....

    March 18, 2024 • Rx Research
  2. Hatsune-miku-voice-text-to-speech

    Hatsune Miku also called Miku Hatsune and officially code-named CV01, is a Vocaloid software voicebank developed by Crypton Future Media and its official anthropomorphic mascot character, a 16-year-old girl with long, turquoise twintails. Miku’s personification has been marketed...

    October 23, 2022 • Rx Research
  3. Molecular Therapies for Auditory/Vestibular Disease Workshop

    The last decade of molecular and genetic research has increased our understanding of basic processes and diseases within the auditory and vestibular systems. The field is...

    October 17, 2022 • Rx Research
  4. Communication Disorders Workshops

    The Epidemiology of Communication Disorders Workshop was held March 29-30, 2005, in Bethesda, Maryland. The purpose was to review current epidemiologic knowledge in the field of...

    October 17, 2022 • Rx Research
  5. Tinnitus Research Workshop

    The NIDCD held a workshop to bring together key people currently doing clinical and basic research in central mechanisms and treatments in tinnitus and others who...

    October 17, 2022 • Rx Research
  6. Language Benchmarks with Autism Spectrum Disorder

    Autism is a neurodevelopmental disorder characterized by primary impairments in social interactions, communication, and repetitive and stereotyped behaviors (American Psychiatric Association, 2000). In addition, autism often...

    October 17, 2022 • Rx Research
  7. Immune Mediated Ear Disease/Hearing Loss

    National Institute on Deafness and Other Communication Disorders (NIDCD) convened a workshop at the Hyatt Regency Bethesda in Bethesda, MD, titled Immune-Mediated Ear Disease/Hearing Loss. The goals...

    October 17, 2022 • Rx Research
  8. Hearing Health Care for Adults with Mild to Moderate Hearing Loss

    Hearing loss (HL) is a public health issue and is among the leading public health concerns. Approximately 17 percent of American adults, or 36 million people,...

    October 17, 2022 • Rx Research
  9. Nonverbal School-Aged Children with Autism

    Goals of the Workshop What do we know about this population? What are the gaps in our knowledge? What are the research opportunities that will address...

    October 17, 2022 • Rx Research
  10. Is Regenerative Therapies Working?

    The purpose of the workshop was to discuss and identify research opportunities that will advance/translate targeted molecular approaches into clinical applications. The working meeting was organized...

    October 17, 2022 • Rx Research